Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Utilization of Natural Language Processing in Venous Thromboembolism Identification

Jonathan Avery, Kylee L Martens, Daniel Nguyen, Ryan Basom, Stephanie Lee, David A. Garcia, Cristhiam Mauricio Rojas Hernandez, Ang Li

Blood (2022) 140 (Supplement 1): 7860–7861.

https://doi.org/10.1182/blood-2022-165426

Published: 2022

Journal Articles

Venous Thromboembolism Risk in Cancer Patients Receiving First-Line Immune Checkpoint Inhibitor Vs. Chemotherapy

Sarah B May, Jennifer La, Emily Milner, Nimrah Riaz, Christopher I Amos, David A. Garcia, Marc Carrier, Neil Zakai, Nhan V Do, Mary Brophy, Vipul Chitalia, J. Michael Gaziano, Nathanael Fillmore, Ang Li

Blood (2022) 140 (Supplement 1): 7968–7970.

https://doi.org/10.1182/blood-2022-162658

Published: 2022

Journal Articles

Derivation and External Validation of Clinical Risk Assessment Model for Cancer Associated Thrombosis in Two Unique U.S. Healthcare Systems

Ang Li, Jennifer La, Sarah B May, Danielle Guffey, Wilson L Da Costa, Jr., Christopher I Amos, Emily Milner, Raka Bandyo, Carolina Granada, Nimrah Riaz, Nhan V Do, Mary Brophy, Vipul Chitalia, J. Michael Gaziano, David A. Garcia, Marc Carrier, Christopher R. Flowers, Neil Zakai, Nathanael Fillmore

Blood (2022) 140 (Supplement 1): 5637–5639.

https://doi.org/10.1182/blood-2022-160017

Published: 2022

Journal Articles

Acquired Hemophilia Following COVID-19 and Influenza Vaccination: A Systematic Review

Kanak Parmar, Shivam Singh, Lukman Tijani, David A. Garcia

Blood (2022) 140 (Supplement 1): 5608–5609.

https://doi.org/10.1182/blood-2022-164546

Published: 2022

Journal Articles

Thrombophilia Testing Patterns, Result Interpretation, and Clinical Outcomes in a Retrospective Cohort of Patients with Retinal Vascular Occlusion

Jonathan Zawadzki, Debbie Jiang, David A. Garcia, Daniel E. Sabath

Blood (2022) 140 (Supplement 1): 5007–5008.

https://doi.org/10.1182/blood-2022-168035

Published: 2022

Journal Articles

Internal and External Validation of the High-2-Low Model: A Predictive Score for Venous Thromboembolism after Allogeneic Transplant

Ang Li, Kylee L Martens, Daniel Nguyen, Gabriela Rondon, Christopher I Amos, Stephanie J. Lee, Ryan Basom, Chris Davis, David A. Garcia, Richard E. Champlin, Elizabeth J. Shpall, Cristhiam Mauricio Rojas Hernandez, Partow Kebriaei

Blood (2021) 138 (Supplement 1): 750.

https://doi.org/10.1182/blood-2021-148234

Published: 2021

Journal Articles

Impact of Race/Ethnicity on Cancer Associated Thrombosis Among Underserved Patients with Cancer

Wilson L Da Costa, Jr., Danielle Guffey, Raka Bandyo, Courtney D Wallace, Carolina Granada, Romil D Patel, Margaret Fitzgerald, Elizabeth Y. Chiao, David A. Garcia, Marc Carrier, Christopher I Amos, Ang Li

Blood (2021) 138 (Supplement 1): 176.

https://doi.org/10.1182/blood-2021-149221

Published: 2021

Journal Articles

Optimizing Cancer Associated Thrombosis (CAT) Risk Assessment Model at a Safety-Net Healthcare System

Ang Li, Wilson L Da Costa, Jr., Danielle Guffey, Raka Bandyo, Courtney D Wallace, Carolina Granada, Romil Patel, Margaret Fitzgerald, Elizabeth Y. Chiao, David A. Garcia, Christopher I Amos, Marc Carrier

Blood (2021) 138 (Supplement 1): 833.

https://doi.org/10.1182/blood-2021-147390

Published: 2021

Journal Articles

A prospective, blinded study of a PF4-dependent assay for HIT diagnosis

Bethany Samuelson Bannow, Deepti M. Warad, Curtis G. Jones, Shannon M. Pechauer, Brian R. Curtis, Daniel W. Bougie, Ruchika Sharma, Diane E. Grill, Mary W. Redman, Parisa R. Khalighi, Rachel R. Leger, Rajiv K. Pruthi, Dong Chen, Daniel E. Sabath, Richard H. Aster, David A. Garcia, Anand Padmanabhan

Blood (2021) 137 (8): 1082–1089.

https://doi.org/10.1182/blood.2020008195

Published: 2021

Includes: Supplemental data

Journal Articles

Frequency of Venous Thromboembolism in 6513 Patients with COVID-19: A Retrospective Study

Mark Crowther, MD, David A. Garcia, MD, Jason Hill, MDMSc, Bryan Savage, Shira Peress, Kevin Chang, Steven Deitelzweig, MD

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-141850

Published: 2020

Journal Articles

High-2-Low Risk Assessment Model to Predict Venous Thromboembolism in Allogeneic Transplant Patients after Platelet Engraftment

Kylee L Martens, MD, Wilson L da Costa, Jr., MD MPH, PhD, Chris Davis, M.S., Madeline Kesten, Stephanie J. Lee, MDMPH, Neil A. Zakai, MDMSc, David A. Garcia, MD, Ang Li, MDMS

Blood (2020) 136 (Supplement 1): 31–32.

https://doi.org/10.1182/blood-2020-134952

Published: 2020

Journal Articles

Comparison of Outcomes and Utilization of Therapy in Multiple Myeloma Patients in the USA and Alberta, Canada

Andrew J. Cowan, MD, Shasank R Chennupati, PharmD, MPH, Yuan Xu, PhD, Ang Li, MDMS, David A. Garcia, MD, Edward Libby, MD, Catherine Fedorenko, MMSci, Scott D Ramsey, MD PhD, Veena Shankaran, MD, Winson Y Cheung, MDMPH

Blood (2020) 136 (Supplement 1): 20–21.

https://doi.org/10.1182/blood-2020-141088

Published: 2020

Journal Articles

D-Dimer As a Prognostic Biomarker for Venous Thromboembolism after Hematopoietic Cell Transplantation

Ang Li, MD, Qian Vicky Wu, PhD, Gary Schoch, Madeline Kesten, Emily Pao, MS, Jingfei Dong, MD PhD, David A. Garcia, MD, Sangeeta R Hingorani, MD MPH

Blood (2019) 134 (Supplement_1): 3645.

https://doi.org/10.1182/blood-2019-127862

Published: 2019

Journal Articles

Meta-Analysis and Cost-Effectiveness Analysis of Low-Dose Direct Oral Anticoagulant for the Prevention of Cancer Associated Thrombosis

Ang Li, MD, Josh J Carlson, PhD, Nicole M. Kuderer, Jordan K Schaefer, MD, Shan Li, PharmD, David A. Garcia, MD, Alok A Khorana, MD, Marc Carrier, MD, Gary H. Lyman, MD MPH

Blood (2019) 134 (Supplement_1): 4669.

https://doi.org/10.1182/blood-2019-127917

Published: 2019

Journal Articles

Comparative Effectiveness of Rasburicase Versus Allopurinol for Cancer Patients with Renal Dysfunction and Hyperuricemia

Kylee L Martens, MD, Parisa R Khalighi, BS, Shan Li, PharmD, Andrew A White, MD, Emily Silgard, MS, Deborah Frieze, PharmD, Elihu H. Estey, MD, David A. Garcia, MD, Sangeeta R Hingorani, MD MPH, Ang Li, MD

Blood (2019) 134 (Supplement_1): 4674.

https://doi.org/10.1182/blood-2019-124058

Published: 2019

Journal Articles

Inherited Thrombophilia and the Risk of Arterial Ischemic Stroke: A Systematic Review and Meta-Analysis

Thita Chiasakul, MD MSc, Elizabeth De Jesus, Jiayi Tong, B.S., Yong Chen, PhD, Mark Crowther, MD, David A. Garcia, MD, Chatree Chai-Adisaksopha, MD, Steven R. Messé, MD, Adam Cuker, MD MS

Blood (2018) 132 (Supplement 1): 2518.

https://doi.org/10.1182/blood-2018-99-110997

Published: 2018

Journal Articles

The Incidence of Thromboembolism for Lenalidomide Versus Thalidomide in Older Patients with Newly Diagnosed Multiple Myeloma

Ang Li, MD, Qian V. Wu, PhD, Greg Warnick, Edward N. Libby, III, MD, David A. Garcia, MD, Gary H. Lyman, MD MPH, FRCP

Blood (2018) 132 (Supplement 1): 361.

https://doi.org/10.1182/blood-2018-99-110500

Published: 2018

Journal Articles

The Platelet Factor-4 (PF4)-Dependent p-Selectin Expression Assay (PEA) Is Highly Accurate for the Detection of Pathogenic HIT Antibodies: Results of a 440-Sample Prospective Blinded Study

Deepti M. Warad, MD, Bethany T Samuelson Bannow, MD, Curtis Jones, BS, Shannon Pechauer, Brian R. Curtis, PhD, Daniel W. Bougie, PhD, Parisa R Khalighi, BS, Diane E. Grill, MS, Rachel Leger, BAE, Ruchika Sharma, MD, Dong Chen, MD PhD, Richard H. Aster, MD, David A. Garcia, MD, Anand Padmanabhan, MD PhD

Blood (2018) 132 (Supplement 1): 416.

https://doi.org/10.1182/blood-2018-99-112475

Published: 2018

Journal Articles

Rivaroxaban Thromboprophylaxis in High-Risk Ambulatory Cancer Patients Receiving Systemic Therapy: Results of a Randomized Clinical Trial (CASSINI)

Blood (2018) 132 (Supplement 1): LBA-1.

https://doi.org/10.1182/blood-2018-120738

Published: 2018

Journal Articles

The HAS-RISC Score for Venous Thromboembolism (VTE) Risk Stratification in Newly Diagnosed Multiple Myeloma Patients Starting Immunomodulatory Drugs (IMID)

Ang Li, MD, Qian V. Wu, PhD, Greg Warnick, Neil A Zakai, MD MSc, Edward N. Libby, III, MD, David A. Garcia, MD, Gary H. Lyman, MD MPH, FRCP

Blood (2018) 132 (Supplement 1): 144.

https://doi.org/10.1182/blood-2018-99-110567

Published: 2018

NARROW

Utilization of Natural Language Processing in Venous Thromboembolism Identification

Venous Thromboembolism Risk in Cancer Patients Receiving First-Line Immune Checkpoint Inhibitor Vs. Chemotherapy

Derivation and External Validation of Clinical Risk Assessment Model for Cancer Associated Thrombosis in Two Unique U.S. Healthcare Systems

Acquired Hemophilia Following COVID-19 and Influenza Vaccination: A Systematic Review

Thrombophilia Testing Patterns, Result Interpretation, and Clinical Outcomes in a Retrospective Cohort of Patients with Retinal Vascular Occlusion

Internal and External Validation of the High-2-Low Model: A Predictive Score for Venous Thromboembolism after Allogeneic Transplant

Impact of Race/Ethnicity on Cancer Associated Thrombosis Among Underserved Patients with Cancer

Optimizing Cancer Associated Thrombosis (CAT) Risk Assessment Model at a Safety-Net Healthcare System

A prospective, blinded study of a PF4-dependent assay for HIT diagnosis

Frequency of Venous Thromboembolism in 6513 Patients with COVID-19: A Retrospective Study

High-2-Low Risk Assessment Model to Predict Venous Thromboembolism in Allogeneic Transplant Patients after Platelet Engraftment

Comparison of Outcomes and Utilization of Therapy in Multiple Myeloma Patients in the USA and Alberta, Canada

D-Dimer As a Prognostic Biomarker for Venous Thromboembolism after Hematopoietic Cell Transplantation

Meta-Analysis and Cost-Effectiveness Analysis of Low-Dose Direct Oral Anticoagulant for the Prevention of Cancer Associated Thrombosis

Comparative Effectiveness of Rasburicase Versus Allopurinol for Cancer Patients with Renal Dysfunction and Hyperuricemia

Inherited Thrombophilia and the Risk of Arterial Ischemic Stroke: A Systematic Review and Meta-Analysis

The Incidence of Thromboembolism for Lenalidomide Versus Thalidomide in Older Patients with Newly Diagnosed Multiple Myeloma

The Platelet Factor-4 (PF4)-Dependent p-Selectin Expression Assay (PEA) Is Highly Accurate for the Detection of Pathogenic HIT Antibodies: Results of a 440-Sample Prospective Blinded Study

Rivaroxaban Thromboprophylaxis in High-Risk Ambulatory Cancer Patients Receiving Systemic Therapy: Results of a Randomized Clinical Trial (CASSINI)

The HAS-RISC Score for Venous Thromboembolism (VTE) Risk Stratification in Newly Diagnosed Multiple Myeloma Patients Starting Immunomodulatory Drugs (IMID)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only